About Dr Reddy's Bevacizumab 100mg Injection (Versavo)
Capitalize on a trending, monumental solution in oncology with Dr Reddys VERSAVO 100 (Bevacizumab 100mg Injection). This meritorious, prescription-only drug is a hot deal for hospitals and clinics seeking advanced, targeted therapy for cancer patients. With its terrific ability to inhibit angiogenesis, VERSAVO 100 is indicated for treatment of metastatic colorectal cancer, glioblastoma, non-small cell lung cancer, and more. Each single-use vial contains 100 mg Bevacizumab (25 mg/mL) in a 4 mL clear to slightly opalescent, colorless to pale brown liquid. Approved by Indian regulatory authorities, it's a landmark in patient-centric cancer care.
Versavo 100 Plant Application & Clinical Use
Dr Reddys Bevacizumab 100mg Injection (Versavo) is formulated for intravenous infusion, strictly within hospital and clinical environments. Its surface of application is the vascular system, delivered directly into patients' veins. Versavo 100 is used for the treatment of various cancers, including metastatic colorectal cancer, non-small cell lung cancer, and glioblastoma, as prescribed by an oncologist. Administration should always be carried out by trained healthcare professionals using aseptic techniques.
Main Export Markets, Certifications, and FOB Port for Versavo 100
Dr Reddys Bevacizumab 100mg Injection (Versavo) is shipped globally, with principal export markets including Asian, African, Middle Eastern, and CIS regions. Each vial is certified and approved by Indian Regulatory Authorities, ensuring high safety and efficacy standards. Shipments are consolidated and dispatched via major Indian FOB ports, delivering excellence to hospitals worldwide. The list price and delivery schedules are available on request, subject to regulatory approval in the destination country.
FAQ's of Dr Reddy's Bevacizumab 100mg Injection (Versavo):
Q: How should Dr Reddys Versavo 100 be administered?
A: Dr Reddys Versavo 100 must be administered as an intravenous infusion, strictly under the supervision of trained healthcare professionals in a hospital or clinical setting. The dosage and administration schedule should be determined by a treating physician.
Q: What cancers does Bevacizumab 100mg Injection (Versavo) treat?
A: Versavo 100 is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, and other malignancies as directed by your oncologist.
Q: Where should Versavo 100 vials be stored before use?
A: Versavo 100 should be stored in a refrigerator at 2C to 8C and must not be frozen. Always check the expiry date before use and keep vials in their original packaging until ready to administer.
Q: What is the process for determining the correct dosage of Versavo 100?
A: The exact dosage for Versavo 100 should be prescribed by the treating physician, based on individual patient factors and clinical indication. Do not self-administer or alter the dosage without medical guidance.
Q: What are the benefits of using Bevacizumab (Versavo) in cancer treatment?
A: Bevacizumab (Versavo) inhibits angiogenesis-the formation of new blood vessels in tumors-thereby restricting tumor growth and supporting improved outcomes in cancer therapy when used as directed by healthcare professionals.